【摘 要】目的：研究恩替卡韦与保肝药物合用对肝硬化失代偿期患者的临床应用效果。方法：随机抽取我院2018年11月～2019年4月收治的80例肝硬化失代偿期患者，按照信封式将其平均分为对照组与观察组，对照组患者运用保肝药物，而观察组肝硬化失代偿期患者需要在保肝药物的基础上运用恩替卡韦的，对比两组患者C3、C4以及各项指标状况。结果：观察组患者血清丙氨酸基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)较对照组明显下降，组间存在差异(P<0.05)。结论：针对肝硬化失代偿期患者运用恩替卡韦与保肝药物联合治疗可以提升治疗效果。

    【关键词】恩替卡韦;保肝药物;肝硬化失代偿期

    Abstract：Objective To study the clinical effect of entecavir combined with hepatoprotective drugs on decompensated patients with liver cirrhosis. Methods： 80 patients with decompensated cirrhosis in our hospital from November 2018 to April 2019 were randomly selected and divided into control group and observation group according to envelope type. The patients in control group were treated with hepatoprotective drugs ......